Essential thrombocythemia in a dog.
A two-year old male Welsh Corgi was referred for persistent thrombocytosis and occasional seizure. Hematological findings indicated marked thrombocytosis, eosinophilia, basophilia and moderate anemia. Bone marrow examination revealed marked megakaryocytic hyperplasia with morphologic abnormality. A diagnosis of essential thrombocythemia was made and the treatment was initiated with combination chemotherapy and maintained by prednisolone and busulfan. The dog successfully achieved complete remission on 100 days after initial presentation and has been good in health without chemotherapy since then.
Mizukoshi
Takeshi
T
Sanyo Animal Medical Center, Okayama, Japan.
Fujino
Yasuhito
Y
Yasukawa
Kuniyoshi
K
Matumoto
Hidefumi
H
Matsumura
Shingo
S
Nagasaki
Teppei
T
Ohno
Koichi
K
Tsujimoto
Hajime
H
Shimoda
Tetsuya
T
D000818:Animals; D002066:Busulfan / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy / Q000473:pathology*; D004285:Dogs; D004359:Drug Therapy, Combination; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D013920:Thrombocythemia, Essential / Q000473:pathology / Q000662:veterinary*; D016896:Treatment Outcome
D011239:Prednisolone; D002066:Busulfan